Non-invasive ventilation in postoperative patients: a systematic review

Chiumello, Davide; Chevallard, Giorgio; Gregoretti, Cesare

doi:10.1007/s00134-011-2210-8

Cited by 193 publications

(128 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[66][67][68][69] Jaber et al 69 suggest that there are 2 potential goals of NIV in the post-operative period: 1) to prevent acute respiratory failure (prophylactic treatment) or, 2) to treat acute respiratory failure and avoid reintubation (curative treatment). Chiumello et al 66 conducted a systematic review of 29 studies including 2,279 subjects. There were 9 studies that evaluated NIV in post-abdominal surgery, 3 in thoracic surgery, 8 in cardiac surgery, 3 in thoraco-abdominal surgery, 4 in bariatric surgery and 2 in post solid organ transplantation.…”

Section: Post-operative Respiratory Failurementioning

confidence: 99%

Noninvasive Ventilation for Acute Respiratory FailureDiscussion

2013

View full text Add to dashboard Cite

Section: Post-operative Respiratory Failurementioning

confidence: 99%

Noninvasive Ventilation for Acute Respiratory FailureDiscussion

2013

View full text Add to dashboard Cite

“…Obese patients and particularly those with OHS are more likely to develop post-operative respiratory failure, have higher rates of pneumonia, and development of atelectasis [21,[35][36][37][38][39][40]. Both upper abdominal and thoracic surgery can result in a restriction of pulmonary function that can persist for several days due to the reduced ability to clear secretions [21].…”

Section: Niv For Obese Patients Undergoing Surgerymentioning

confidence: 99%

Predictors of Noninvasive Ventilation Failure in Critically Ill Obese Patients: A Brief Narrative Review

Nicolini¹,

Lemyze

Esquinas

et al. 2017

Advances in Respiratory Medicine

View full text Add to dashboard Cite

Non-invasive ventilation ( NIV ) has been used successfully for the management of acute respiratory failure (ARF) more often in the last two decades than previously. Unfortunately, NIV can have failure rates ranging from 5% to 50% and patient selection is the key to success. There are particular groups of patients that are more likely to benefit from NIV. For patients with hypoventilation syndrome (OHS) this treatment can be beneficial. This review seeks to evaluate the effectiveness of NIV in acute ARF and determine predictors of NIV failure in morbidly obese patients. Only a few studies have investigated NIV success or failure in these patients. NIV was most often effective when patients were carefully selected. Obese patients who exhibited early NIV failure had a high severity score at admission. In contrast, more than half of hypercapnic patients with decompensated OHS exhibited a delayed but successful response to NIV. Patients with decompensation of OHS had better prognosis and response to NIV than other hypercapnic patients. They required more aggressive NIV settings, a longer time to reduce paCO 2 levels, and more frequently a delayed but successful response to NIV which should encourage the use of NIV rather than early intubation. Since clear predictors of NIV failure have not been identified, a strict and prolonged monitoring is mandatory.

show abstract

“…Th e curiosity about the probable benefi ts of NIV gave rise to studies dealing with the prophylactic and curative use of NIV postoperatively and intraoperatively 14,24 . Tobias was the fi rst to publish postoperative use of NIV 4 .…”

Section: Postoperative Pulmonary Complications (Ppc)mentioning

confidence: 99%